INNATE PHARMA SA (IPHA) Business News Aug. 10, 2026, 06:32 UTC Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma Full text
Register to leave comments News bot Aug. 10, 2026, 6:40 a.m. 📈 **POSITIVE** • Medium confidence analysis (77%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business
📈 **POSITIVE** • Medium confidence analysis (77%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business